SOURCE: Healthnostics, Inc.

July 06, 2010 10:00 ET

Healthnostics Agrees to Acquire Medical Manufacturing Company

NEW YORK, NY--(Marketwire - July 6, 2010) -  Healthnostics, Inc. (PINKSHEETS: HNSS), a medical and biotechnology analytics company, has agreed to acquire a medical manufacturing company on multi-year terms that include benchmarks of a first year profit target range of $300,000-$600,000 and a second year target range of $600,000-$900,000. These numbers do not include the benefits of reinvestment by the company in (a) manufacturing, (b) existing company products, and (c) reduction of outstanding shares through company purchases. As a result, the medical manufacturing profits can potentially have a multiplier effect on the Company's earnings per share.

The Company will continue to provide additional details as its acquisition strategy continues to unfold.

"We are pleased to provide this acquisition update showing the significant benefit that can accrue for the Company and stockholders," said Alan Grofe, President.

About Healthnostics

Healthnostics, Inc. is a medical and biotechnology analytics company that provides comprehensive patient clinical monitoring and risk management systems to acute care hospitals and utilizes its Internet portals to deliver medical and biotechnology resource information to industry professionals as well as to the general public. Healthnostics' major products include: MedGuardian, a patient care monitoring and risk management system for hospitals that is fully Web-based; and through the MedBioWeb subsidiary, MedBioWorld™, one of the largest professional medical and biotechnology directory resource and reference portal sites on the Internet, and FamilyMedicalNet, a companion consumer healthcare information portal.

For further information please visit Healthnostics, MedBioWorld, and FamilyMedicalNet

And visit us on Facebook at

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

Contact Information